Skip to main content
While praiseworthy, a Centers for Medicare & Medicaid Services (CMS) decision to halt payment on additional costs generated by certain infections should have gone further and included methicillin-resistant Staphylococcus aureus (MRSA), a consumer advocacy group argues.

Consumers, hospital critics welcome CMS changes